Why the study?
Does AT1 receptor blockade or insulin prevent PKC activation and TnI phosphorylation in cardiocytes of diabetic rats?
Does AT1 receptor blockade or insulin prevent PKC activation and TnI phosphorylation in cardiocytes of diabetic rats?
Angiotensin II receptor blockade prevents PKC epsilon activation and troponin I phosphorylation in diabetic rat hearts, suggesting a mechanism for its protective effect against diabetic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
AT1 blockade may mitigate diabetic cardiomyopathy via PKCε-TnI in rats; leaves open clinical translation and human trials.
Malhotra et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: